Fractyl Health, Inc. Common Stock (GUTS) Stock Analysis

Fractyl Health, Inc. Common Stock (GUTS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.79, carries a market capitalization of $137.58M. This page summarizes the public market data, fundamentals, and frequently asked questions for GUTS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.79
• Market Cap: $137.58M
• EPS: $-1.31
• 52-Week High: $3.03
• 52-Week Low: $0.38

Market Sentiment

Fractyl Health, Inc. Common Stock currently has a Bullish sentiment score of 0.29.

About Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. (GUTS) is a pioneering metabolic therapeutics company headquartered in Lexington, Massachusetts, dedicated to transforming the management of type 2 diabetes (T2D) and obesity. By harnessing advanced research and R&D capabilities, Fractyl is developing innovative therapies that address the underlying mechanisms of these prevalent conditions, aiming to improve long-term patient outcomes. The company's commitment to tackling the root causes of metabolic diseases positions it...

GNG Research Analysis

GNG Research scores Fractyl Health, Inc. Common Stock (GUTS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GUTS.

Frequently Asked Questions

Does GUTS pay dividends?

Fractyl Health, Inc. Common Stock (GUTS) does not currently pay a regular dividend.

What is GUTS's market cap?

Fractyl Health, Inc. Common Stock (GUTS) has a market capitalization of $137.58M with a current stock price of $0.79.